Kimball to run #42 at Indy in honor of new diabetes control drug
Novo Nordisk, Chip Ganassi Racing Teams and Charlie Kimball will honor the diabetes community by switching from #83 to #42 for the Indy 500, referencing the 42-hour duration of action of Tresiba.
Tresiba is a once-daily, long-acting basal insulin approved for blood sugar control in adults with diabetes, which was launched by Novo Nordisk earlier this year.
Ganassi will change the number of Kimball’s Tresiba Chevrolet from its usual No. 83 to No. 42 at the 2016 Indianapolis 500.
Kimball was diagnosed with type 1 diabetes in 2007, and in addition to sporting the logo on his car, takes Tresiba, along with a mealtime insulin, as part of his daily diabetes management.
He will borrow the number from fellow CGRT teammate, Kyle Larson, Ganassi’s NASCAR ace who finished second in yesterday’s race at Dover.
Larson has a cousin living with diabetes, so the program has a personal tie for him. Larson’s No. 42 NSCS car will carry Kimball’s name on it for the Coca-Cola 600, held the same day as the Indy 500.
Tresiba lasts at least 42 hours after eight once-daily injections (0.4 U/kg). Kimball’s car will also carry the name of 42 leaders in the diabetes community including Dominique Wilkins, Billie Jean King, diabetes organizations such as JDRF, and first all-diabetes professional cycling team, Team Novo Nordisk.
Additionally, Novo Nordisk will make a $4,200 donation to the Indiana Chapter of the American Diabetes Association (ADA) on behalf of the Verizon IndyCar Series driver who is leading the race after the 42nd lap of the Indianapolis 500.
Novo Nordisk will also make the same $4,200 donation to the Charlotte Chapter of the ADA on behalf of the NSCS driver who leads the Coke 600 after lap 42.
Kimball, who has partnered with Novo Nordisk for eight years, commented: “The 100th running of the Indianapolis 500 will be the highlight of this year’s season and it gives me a great opportunity to honor the diabetes community and help inspire those people living with or affected by diabetes.
“As a racecar driver and a person living with diabetes, the duration of action of Tresiba® is important to me and plays an important role in my management plan.”
Said Ganassi, “It’s been great to see Novo Nordisk use their racing partnership with Chip Ganassi Racing Teams to launch one of their brands, and I love that we’re strengthening our ‘one team’ mantra with the sharing of the number 42 across different series.
“The number 83 is obviously very meaningful to both Charlie and myself,” added Ganassi who in 1983 drove to eighth in the Indy 500 in a Wildcat designed by Charlie’s father Gordon.
“But the number 42 is also just as meaningful with this product and the diabetes community. Charlie had a great run last year at the 500, so hopefully the #42 will bring Novo Nordisk Chip Ganassi Racing and Charlie their first Indianapolis 500 victory.”
Stefan Wilson: “Monday is the biggest day of my career”
Six former winners headline 100th Indianapolis 500 entry list
About this article
|Location||Indianapolis Motor Speedway|
|Teams||Chip Ganassi Racing|